Skip to main content

Table 4 Factors associated with cervical cancer in CIN3+ plus study group compared with the Swiss Health Survey

From: Human papillomavirus genotype distribution and socio-behavioural characteristics in women with cervical pre-cancer and cancer at the start of a human papillomavirus vaccination programme: the CIN3+ plus study

  CIN3+ plus study group n = 273 Swiss Health Survey n = 3537 p-value
% or mean (95% CI) % or mean (95% CI)
Number of sexual partners in the last 12 months
 0 9.2 13.8 < 0.001a
 1 74.0 78.8
  ≥ 2 15.4 6.8
 Unknown 0.0 0.0
 No answer 1.5 0.6
Age at first sexual intercourseb 17.5 (17.2–17.9) 18.1 (17.9–18.2) 0.005
Reported hormonal contraception use in the last 12 monthsc 35.5 41.7 0.072
Current smoker 38.5 25.6 < 0.001
61.5 74.4
Have you ever had a Pap-test?d
 Yes 89.0 81.5 0.002d
 No 8.8 16.3
 Unknown 1.1 0.5
 No answer 1.1 0.0
 Not asked 0.0 1.7
  1. Abbreviations: CI confidence interval
  2. aUnknown, no answer and not asked categories were not included in statistical analysis
  3. bThe number of observations for age at first sex was 270 for the CIN3 + plus study group and 2914 for the Swiss Health Survey
  4. cIncludes any intrauterine device for the Swiss Health Survey
  5. dWomen were asked if they ever had a cervical cancer screening test before the start of their current illness for the CIN3 + plus study